Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Overseas travel
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
14 November 2018
Leukaemia patients are now a step closer to personalised treatments after a British study looked at the role gene mutations play in blood cancers.
[more...]
13 November 2018
A quick scan of the blood vessels in a patient's neck could soon be a critical part of future dementia screening, new research has suggested.
10 November 2018
The NHS spends more than £1 billion a year on prescriptions for people with diabetes, new figures show.
09 November 2018
Woman who smoke, have diabetes, or high blood pressure are more likely to suffer a heart attack than men with the same risk factors, a new study claims.
08 November 2018
Millions of UK pensioners feel they don't have anyone they can turn to for help, a leading charity has warned.
07 November 2018
Over a quarter of medical workers are still reluctant to recommend e-cigarettes to smokers despite being told to do so by health authorities, a new survey has revealed.
06 November 2018
A new direct flight between Manchester and Mumbai could boost the economy of northern England to the tune of £400 million, a new report suggests.
02 November 2018
Air travellers could soon face restrictions on the amount of alcohol they can drink before flying, under plans currently being considered by the government.
01 November 2018
A vegan diet could help people living with diabetes to better manage their condition, a new review suggests.
31 October 2018
Electric planes could soon be flying on short-haul routes in Europe, according to the boss of EasyJet.
30 October 2018
UK air travellers waste up to £175 million every year on seat allocations that they don't need, a new study has revealed.
27 October 2018
Nearly a third of pregnant women had their labour induced last year, leading experts to link the figure with rising maternal age and obesity.